DOCSLIB.ORG

Mice in Inflammation Psoriasiform Skin IL-22 Is Required for Imiquimod-Induced

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mice in Inflammation Psoriasiform Skin IL-22 Is Required for Imiquimod-Induced IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice Astrid B. Van Belle, Magali de Heusch, Muriel M. Lemaire, Emilie Hendrickx, Guy Warnier, Kyri This information is current as Dunussi-Joannopoulos, Lynette A. Fouser, Jean-Christophe of September 29, 2021. Renauld and Laure Dumoutier J Immunol published online 30 November 2011 http://www.jimmunol.org/content/early/2011/11/30/jimmun ol.1102224 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 29, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published November 30, 2011, doi:10.4049/jimmunol.1102224 The Journal of Immunology IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice Astrid B. Van Belle,*,† Magali de Heusch,*,† Muriel M. Lemaire,*,† Emilie Hendrickx,*,† Guy Warnier,*,† Kyri Dunussi-Joannopoulos,‡ Lynette A. Fouser,‡ Jean-Christophe Renauld,*,†,1 and Laure Dumoutier*,†,1 Psoriasis is a common chronic autoimmune skin disease of unknown cause that involves dysregulated interplay between immune cells and keratinocytes. IL-22 is a cytokine produced by the TH1, TH17, and TH22 subsets that are functionally implicated in the psoriatic pathology. We assessed the role of IL-22 in a mouse model where psoriasiform skin inflammation is triggered by topical application of the TLR7/8 agonist imiquimod. At the macroscopic level, scaly skin lesions induced by daily applications of imiqui- mod in wild-type mice were almost totally absent in IL-22–deficient mice or in mice treated with a blocking anti–IL-22 Ab. At the microscopic level, IL-22–deficient mice showed a dramatic decrease in the development of pustules and a partial decrease in Downloaded from acanthosis. At the molecular level, the absence or inhibition of IL-22 strongly decreased the expression of chemotactic factors such as CCL3 and CXCL3 and of biomarkers such as S100A8, S100A7, and keratin 14, which reflect the antimicrobial and hyper- proliferative responses of keratinocytes. IL-22 also played a major role in neutrophil infiltration after imiquimod treatment. IL-23 was required for IL-22 production, and gd TCR lymphocytes represented the major source of IL-22 in lymph nodes from imiquimod-treated mice. However, T cells were not absolutely required for IL-22 production because imiquimod-induced IL- 22 expression in the skin is still preserved in Rag22/2 mice. Taken together, our data show that IL-22 is required for psoriasis-like http://www.jimmunol.org/ lesions in the mouse imiquimod model and is produced by both T cells and innate immune cells. The Journal of Immunology, 2012, 188: 000–000. L-22 is a cytokine related to IL-10 for its structure and to IL- eration of keratinocytes and induced hyperplasia of reconstituted 17 for its cellular pattern of production (1). This cytokine can epidermis (4). I hardly be classified as a pro- or anti-inflammatory cytokine. These biological activities are expected to be beneficial during For instance, analysis of IL-22–deficient mice indicated that it wound healing and infectious processes but might contribute plays a pathogenic role in an arthritis model (2) while being to skin lesions of patients with psoriasis disease, one of the most by guest on September 29, 2021 protective in several colitis models (3). The main physiological common autoimmune-mediated chronic inflammatory skin dis- role of IL-22 appears to be related to wound healing and innate orders that affects ∼2% of the general population (10). Increased antimicrobial responses, because its receptor is mainly expressed levels of Th17 cells and their associated cytokines including IL- by nonhematopoietic cells at body barriers including epithelial 23, IL-17, and IL-22 have been found in human psoriatic skin (6, cells of the lung and gastrointestinal tract and keratinocytes (1). 11, 12). Elevated IL-22 concentrations were measured in plasma In vitro studies showed that IL-22 activates STAT3 (4–6) and from patients and IL-22 production correlated positively with upregulates the expression of proinflammatory and antimicrobial severity of the disease and negatively with response to therapy molecules such as S100A7, S100A8, S100A9, and b-defensins in suggesting a significant role of this cytokine in psoriasis (5, 7, 13). human keratinocytes (4–7), alone or in synergy with IL-17 or TNF T lymphocytes appeared to represent a major source of IL-22 in (8, 9). IL-22 also regulates the cellular differentiation and prolif- skin lesions (7) and treatment with cyclosporine A downregulated both IL-17 and IL-22 expression in those patients (14). *Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium; †de Duve Insti- Psoriasis is not observed in animals other than humans, but tute, Universite´ catholique de Louvain, B-1200 Brussels, Belgium; and ‡Inflammation a large number of mouse models have been set up to mimic at least and Autoimmunity Research Unit, Pfizer BioTherapeutics Research and Development, some aspects of the human disease (15, 16). Psoriasis lesions Cambridge, MA 02140 1 are characterized by several histological features including 1) a J.-C.R. and L.D. share senior coauthorship. thickened epidermis caused by keratinocyte proliferation that is Received for publication August 4, 2011. Accepted for publication November 2, called acanthosis, 2) retention of nuclei in the stratum corneum 2011. (parakeratosis) that arises from an aberrant differentiation of This work was supported in part by the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister’s Office, Science Policy keratinocytes, and 3) inflammatory cell infiltrates in the epidermis Programming, and by the Actions de Recherche Concerte´es of the Communaute´ and dermis (17, 18). IL-22–transgenic mice die soon after birth Franc¸aise de Belgique. L.D. is a Research Associate and A.B.V.B. is a Research with acanthosis and hyperkeratosis that are reminiscent of such Fellow with the Fonds National de la Recherche Scientifique, Belgium. psoriatic lesions (19). Acanthosis can also be induced in wild-type Address correspondence and reprint request to Dr. Jean-Christophe Renauld and Laure Dumoutier, Ludwig Institute for Cancer Research, Avenue Hippocrate 74, 1200 mice by intradermal injection of rIL-23, and this effect is partially Brussels, Belgium. E-mail addresses: [email protected] and laure.dumoutier@bru. abolished in IL-22–deficient mice (20). The role of IL-22 is also licr.org supported by a graft versus host disease (GVHD) mouse model Abbreviations used in this article: GVHD, graft versus host disease; Ngp, neutro- that is based on the transfer of CD4+CD45RBhi T lymphocytes, philic granule protein; qPCR, quantitative PCR. depleted of regulatory T cells, into immunodeficient mice. The Copyright Ó 2011 by The American Association of Immunologists, Inc. 0022-1767/11/$16.00 recipient mice develop acanthosis, elevated levels of antimicrobial www.jimmunol.org/cgi/doi/10.4049/jimmunol.1102224 2 ROLE OF IL-22 IN IMIQUIMOD-INDUCED PSORIASIS peptides and inflammatory infiltrates that can be abolished by Diff-Quick solutions (Medion Diagnostics Ag, Du¨dingen, Switzerland). anti–IL-22 Abs (21). Interestingly, this same GVHD mouse model Percentages of neutrophils were counted on five different areas (with ∼200 can also result in colitis that is exacerbated by IL-22 inhibition, in cells) for each cytospin. Cells from lymph nodes were extracted by mechanical disruption and contrast to the effect in the skin, demonstrating the dual activity resuspended in Iscove Dulbecco medium. For intracellular staining, cells of this cytokine in inflammation (3). were incubated at 37˚C in the presence of GolgiStop solution (BD Bio- More recently, topical treatment with imiquimod, a ligand for sciences) and IL-23 (10 ng/ml) and IL-2 (400 U/ml). After 4 h, cells were TLR7 and TLR8 was reported as a novel mouse model for stained with Abs specific for cell surface Ags at 4˚C. Cells were then fixed, permeabilized, and processed for intracellular staining using the Cytofix/ psoriasis-like skin inflammation, inducing acanthosis, parakeratosis, Cytoperm Plus Kit (BD Biosciences). The mAbs specific to murine Ags and a mixed inflammatory infiltrate (22). Imiquimod is used in used in this study were MH22B2 (anti–IL-22) and MM17F3 (anti–IL- humans for topical treatment of genital and perianal warts caused 17A), which were produced in our laboratory (32), whereas PC61 (anti- by human papillomavirus (23), actinic keratosis, and superficial CD25), 17A2 (anti-CD3), GK1.5 (anti-CD4), H57-597 (anti-TCRb), and basal cell carcinoma (24, 25). Clinical application of imiquimod GL3 (anti-TCRgd) were purchased from BioLegend. can also induce psoriasis or exacerbate the disease in patients T lymphocyte adoptive transfer with a well-controlled psoriasis (26–30). Spleen cell suspensions from BALB/c mice were prepared by mechanical Recently, a pivotal role of the IL-23/IL-17 axis was demonstrated disruption and RBC lysis. The AutoMACS system from Miltenyi Biotec in the mouse skin inflammation induced by imiquimod (22). In this (Bergisch Gladbach, Germany) was used to isolate T lymphocytes, based on study, we show that IL-22–deficient mice are almost totally pro- CD5 expression following the manufacturer’s instructions.
Load more

Recommended publications
  • The Chemokine System in Innate Immunity
    Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press The Chemokine System in Innate Immunity Caroline L. Sokol and Andrew D. Luster Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 Correspondence: [email protected] Chemokines are chemotactic cytokines that control the migration and positioning of immune cells in tissues and are critical for the function of the innate immune system. Chemokines control the release of innate immune cells from the bone marrow during homeostasis as well as in response to infection and inflammation. Theyalso recruit innate immune effectors out of the circulation and into the tissue where, in collaboration with other chemoattractants, they guide these cells to the very sites of tissue injury. Chemokine function is also critical for the positioning of innate immune sentinels in peripheral tissue and then, following innate immune activation, guiding these activated cells to the draining lymph node to initiate and imprint an adaptive immune response. In this review, we will highlight recent advances in understanding how chemokine function regulates the movement and positioning of innate immune cells at homeostasis and in response to acute inflammation, and then we will review how chemokine-mediated innate immune cell trafficking plays an essential role in linking the innate and adaptive immune responses. hemokines are chemotactic cytokines that with emphasis placed on its role in the innate Ccontrol cell migration and cell positioning immune system. throughout development, homeostasis, and in- flammation. The immune system, which is de- pendent on the coordinated migration of cells, CHEMOKINES AND CHEMOKINE RECEPTORS is particularly dependent on chemokines for its function.
    [Show full text]
  • Exploration of Prognostic Biomarkers and Therapeutic Targets in the Microenvironment of Bladder Cancer Based on CXC Chemokines
    Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC Chemokines Xiaoqi Sun Department of Urology, Kaiping Central Hospital, Kaiping, 529300, China Qunxi Chen Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China Lihong Zhang Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China Jiewei Chen Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China Xinke Zhang ( [email protected] ) Sun Yat-sen University Cancer Center Research Keywords: Bladder cancer, Biomarkers, CXC Chemokines, Microenvironment Posted Date: February 24th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-223127/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/29 Abstract Background: Bladder cancer (BLCA) has a high rate of morbidity and mortality, and is considered as one of the most malignant tumors of the urinary system. Tumor cells interact with surrounding interstitial cells, playing a key role in carcinogenesis and progression, which is partly mediated by chemokines. CXC chemokines exert anti‐tumor biological roles in the tumor microenvironment and affect patient prognosis. Nevertheless, their expression and prognostic values patients with BLCA remain unclear. Methods: We used online tools, including Oncomine, UALCAN, GEPIA, GEO databases, cBioPortal, GeneMANIA, DAVID 6.8, Metascape, TRUST (version 2.0), LinkedOmics, TCGA, and TIMER2.0 to perform the relevant analysis. Results: The mRNA levels of C-X-C motif chemokine ligand (CXCL)1, CXCL5, CXCL6, CXCL7, CXCL9, CXCL10, CXCL11, CXCL13, CXCL16, and CXCL17 were increased signicantly increased, and those of CXCL2, CXCL3, and CXCL12 were decreased signicantly in BLCA tissues as assessed using the Oncomine, TCGA, and GEO databases.
    [Show full text]
  • Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1
    pathogens Article Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1 Acacia F. Dishman 1,2,†, Jie He 3,†, Brian F. Volkman 1,* and Anna R. Huppler 3,* 1 Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA; [email protected] 2 Medical Scientist Training Program, Medical College of Wisconsin, Milwaukee, WI 53226, USA 3 Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA; [email protected] * Correspondence: [email protected] (B.F.V.); [email protected] (A.R.H.) † These authors contributed equally. Abstract: Candida species cause serious infections requiring prolonged and sometimes toxic therapy. Antimicrobial proteins, such as chemokines, hold great interest as potential additions to the small number of available antifungal drugs. Metamorphic proteins reversibly switch between multiple different folded structures. XCL1 is a metamorphic, antimicrobial chemokine that interconverts between the conserved chemokine fold (an α–β monomer) and an alternate fold (an all-β dimer). Previous work has shown that human XCL1 kills C. albicans but has not assessed whether one or both XCL1 folds perform this activity. Here, we use structurally locked engineered XCL1 variants and Candida killing assays, adenylate kinase release assays, and propidium iodide uptake assays to demonstrate that both XCL1 folds kill Candida, but they do so via different mechanisms. Our results suggest that the alternate fold kills via membrane disruption, consistent with previous work, and the chemokine fold does not. XCL1 fold-switching thus provides a mechanism to regulate Citation: Dishman, A.F.; He, J.; the XCL1 mode of antifungal killing, which could protect surrounding tissue from damage associ- Volkman, B.F.; Huppler, A.R.
    [Show full text]
  • With Immunoregulatory Invariant NK T Cells Schwann Cells and Potential Interactions Expression of Cd1d Molecules by Human
    Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells This information is current as Jin S. Im, Nikos Tapinos, Gue-Tae Chae, Petr A. Illarionov, of September 27, 2021. Gurdyal S. Besra, George H. DeVries, Robert L. Modlin, Peter A. Sieling, Anura Rambukkana and Steven A. Porcelli J Immunol 2006; 177:5226-5235; ; doi: 10.4049/jimmunol.177.8.5226 http://www.jimmunol.org/content/177/8/5226 Downloaded from References This article cites 60 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/177/8/5226.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells1 Jin S.
    [Show full text]
  • Role of Chemokines in Hepatocellular Carcinoma (Review)
    ONCOLOGY REPORTS 45: 809-823, 2021 Role of chemokines in hepatocellular carcinoma (Review) DONGDONG XUE1*, YA ZHENG2*, JUNYE WEN1, JINGZHAO HAN1, HONGFANG TUO1, YIFAN LIU1 and YANHUI PENG1 1Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050051; 2Medical Center Laboratory, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai 200065, P.R. China Received September 5, 2020; Accepted December 4, 2020 DOI: 10.3892/or.2020.7906 Abstract. Hepatocellular carcinoma (HCC) is a prevalent 1. Introduction malignant tumor worldwide, with an unsatisfactory prognosis, although treatments are improving. One of the main challenges Hepatocellular carcinoma (HCC) is the sixth most common for the treatment of HCC is the prevention or management type of cancer worldwide and the third leading cause of of recurrence and metastasis of HCC. It has been found that cancer-associated death (1). Most patients cannot undergo chemokines and their receptors serve a pivotal role in HCC radical surgery due to the presence of intrahepatic or distant progression. In the present review, the literature on the multi- organ metastases, and at present, the primary treatment methods factorial roles of exosomes in HCC from PubMed, Cochrane for HCC include surgery, local ablation therapy and radiation library and Embase were obtained, with a specific focus on intervention (2). These methods allow for effective treatment the functions and mechanisms of chemokines in HCC. To and management of patients with HCC during the early stages, date, >50 chemokines have been found, which can be divided with 5-year survival rates as high as 70% (3). Despite the into four families: CXC, CX3C, CC and XC, according to the continuous development of traditional treatment methods, the different positions of the conserved N-terminal cysteine resi- issue of recurrence and metastasis of HCC, causing adverse dues.
    [Show full text]
  • Fas Ligand Elicits a Caspase-Independent Proinflammatory Response in Human Keratinocytes: Implications for Dermatitis Sherry M
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Serveur académique lausannois ORIGINAL ARTICLE See related commentary on pg 2364 Fas Ligand Elicits a Caspase-Independent Proinflammatory Response in Human Keratinocytes: Implications for Dermatitis Sherry M. Farley1, Anjali D. Dotson1, David E. Purdy1, Aaron J. Sundholm1, Pascal Schneider2, Bruce E. Magun1 and Mihail S. Iordanov1 Fas ligand (FasL) causes apoptosis of epidermal keratinocytes and triggers the appearance of spongiosis in eczematous dermatitis. We demonstrate here that FasL also aggravates inflammation by triggering the expression of proinflammatory cytokines, chemokines, and adhesion molecules in keratinocytes. In HaCaT cells and in reconstructed human epidermis (RHE), FasL triggered a NF-kB-dependent mRNA accumulation of inflammatory cytokines (tumor necrosis factor-a, IL-6, and IL-1b), chemokines (CCL2/MCP-1, CXCL1/GROa, CXCL3/GROg, and CXCL8/IL-8), and the adhesion molecule ICAM-1. Oligomerization of Fas was required both for apoptosis and for gene expression. Inhibition of caspase activity abolished FasL-dependent apoptosis; however, it failed to suppress the expression of FasL-induced genes. Additionally, in the presence of caspase inhibitors, but not in their absence, FasL triggered the accumulation of CCL5/RANTES (regulated on activation normal T cell expressed and secreted) mRNA. Our findings identify a novel proinflammatory role of FasL in keratinocytes that is independent of caspase activity and is separable from apoptosis. Thus, in addition to causing spongiosis, FasL may play a direct role in triggering and/or sustaining inflammation in eczemas. Journal of Investigative Dermatology (2006) 126, 2438–2451. doi:10.1038/sj.jid.5700477; published online 20 July 2006 INTRODUCTION increased local concentration of procaspase 8 allows for Apoptosis (Kerr et al., 1972), the principal mechanism for its spontaneous autocatalytic cleavage and activation by elimination of damaged cells in metazoan organisms (Edinger ‘‘induced proximity’’ (Muzio et al., 1998).
    [Show full text]
  • CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice
    ORIGINAL ARTICLE JBMR CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice Michele Doucet, Swaathi Jayaraman, Emily Swenson, Brittany Tusing, Kristy L Weber,Ã and Scott L Kominsky Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA ABSTRACT CCL20 is a member of the macrophage inflammatory protein family and is reported to signal monogamously through the receptor CCR6. Although studies have identified the genomic locations of both Ccl20 and Ccr6 as regions important for bone quality, the role of CCL20/CCR6 signaling in regulating bone mass is unknown. By micro–computed tomography (mCT) and histomorphometric analysis, we show that global loss of Ccr6 in mice significantly decreases trabecular bone mass coincident with reduced osteoblast numbers. Notably, CCL20 and CCR6 were co-expressed in osteoblast progenitors and levels increased during osteoblast differentiation, indicating the potential of CCL20/CCR6 signaling to influence osteoblasts through both autocrine and paracrine actions. With respect to autocrine effects, CCR6 was found to act as a functional G protein–coupled receptor in osteoblasts and although its loss did not appear to affect the number or proliferation rate of osteoblast progenitors, differentiation was significantly inhibited as evidenced by delays in osteoblast marker gene expression, alkaline phosphatase activity, and mineralization. In addition, CCL20 promoted osteoblast survival concordant with activation of the PI3K-AKT pathway. Beyond these potential autocrine effects, osteoblast-derived CCL20 stimulated the recruitment of macrophages and T cells, known facilitators of osteoblast differentiation and survival. Finally, we generated mice harboring a global deletion of Ccl20 and found that Ccl20-/- mice exhibit a reduction in bone mass similar to that observed in Ccr6-/- mice, confirming that this phenomenon is regulated by CCL20 rather than alternate CCR6 ligands.
    [Show full text]
  • Recombinant Human GRO Gamma (CXCL3) Recombinant Human Protein Expressed in E
    Catalog # Aliquot Size G873-40N-10 10 µg G873-40N-100 100 µg G873-40N-1000 1 mg Recombinant Human GRO gamma (CXCL3) Recombinant human protein expressed in E. coli cells Catalog # G873-40N Lot # G3211-47 Product Description Specific Activity Recombinant Human GRO gamma (CXCL3) was expressed in E. coli cells. The protein accession number is P19876 Gene Aliases C-X-C motif chemokine 3, GRO-gamma(1-73), Growth-regulated protein gamma, GRO-gamma, Macrophage inflammatory protein 2-beta, MIP2-beta Recombinant Human Growth Regulated Oncogene Gamma (CXCL3) Endotoxin Level <1.0 EU/µg of recombinant protein as determined by the LAL method. Determined by its ability to chemoattract 293 transfected Formulation CXCR2 cells using a concentration range of 10-100 ng/mL. Recombinant GRO-gamma/CXCL3 was lyophilized from a 0.2 µm Purity filtered concentrated (1.0 mg/mL) solution in 40 mM NaCl, 10 mM PB, pH 7.0. Recombinant Human GRO Reconstitution Protocol gamma (CXCL3) resolved on a 17% SDS-PAGE gel under reducing conditions and stained with A quick spin of the vial followed by reconstitution in distilled water Coomassie Brilliant Blue G-250 to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. Approx. MW 8.0 kDa Storage and Stability The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six Recombinant Human GRO gamma months, with a carrier protein without detectable loss of activity.
    [Show full text]
  • Establishment of HIV-1 Latency in Resting CD4+ T Cells Depends on Chemokine-Induced Changes in the Actin Cytoskeleton
    Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton Paul U. Camerona,b,c,1, Suha Salehb,1, Georgina Sallmannb, Ajantha Solomonb, Fiona Wightmanb, Vanessa A. Evansb, Genevieve Boucherd, Elias K. Haddadd,Rafick-Pierre Sekalyd, Andrew N. Harmane, Jenny L. Andersonf, Kate L. Jonesf, Johnson Makf,g, Anthony L. Cunninghame, Anthony Jaworowskib,c,f, and Sharon R. Lewina,b,f,2 aInfectious Diseases Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia; Departments of bMedicine and cImmunology, Monash University, Melbourne 3004, Australia; dLaboratoire d’Immunologie, Centre de Recherche de Centre Hospitalier de L’Universitie de Montreal, Saint-Luc, Quebec, Canada; eWestmead Millenium Research Institute, Westmead 2145, Australia; fCentre for Virology, Burnet Institute, Melbourne 3004, Australia; and gDepartment of Biochemistry and Molecular Biology, Department of Microbiology, Monash University, Clayton 3800, Australia Edited by Malcolm A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved August 23, 2010 (received for review March 8, 2010) Eradication of HIV-1 with highly active antiretroviral therapy mokines, in addition to CXCR4 ligands may facilitate HIV-1 + (HAART) is not possible due to the persistence of long-lived, entry and integration in resting CD4 T cells and that this was latently infected resting memory CD4+ T cells. We now show that mediated via activation of actin. + HIV-1 latency can be established in resting CD4+ T cells infected We now show that the exposure of resting CD4 T cells to with HIV-1 after exposure to ligands for CCR7 (CCL19), CXCR3 the chemokines CCL19, CXCL10, and CCL20, all of which fi (CXCL9 and CXCL10), and CCR6 (CCL20) but not in unactivated regulate T-cell migration, allows for ef cient HIV-1 nuclear lo- + calization and integration of the HIV-1 provirus, that this oc- CD4 T cells.
    [Show full text]
  • A Role for the Pattern Recognition Receptor Nod2 in Promoting Recruitment of CD103&Plus; Dendritic Cells to the Colon In
    ARTICLES nature publishing group A role for the pattern recognition receptor Nod2 in promoting recruitment of CD103 þ dendritic cells to the colon in response to Trichuris muris infection R Bowcutt1,4, M Bramhall1, L Logunova1, J Wilson2, C Booth2, SR Carding3, R Grencis1 and S Cruickshank1 The ability of the colon to generate an immune response to pathogens, such as the model pathogen Trichuris muris,isa fundamental and critical defense mechanism. Resistance to T. muris infection is associated with the rapid recruitment of dendritic cells (DCs) to the colonic epithelium via epithelial chemokine production. However, the epithelial–pathogen interactions that drive chemokine production are not known. We addressed the role of the cytosolic pattern recognition receptor Nod2. In response to infection, there was a rapid influx of CD103 þ CD11c þ DCs into the colonic epithelium in wild-type (WT) mice, whereas this was absent in Nod2 À / À animals. In vitro chemotaxis assays and in vivo experiments using bone marrow chimeras of WT mice reconstituted with Nod2 À / À bone marrow and infected with T. muris demonstrated that the migratory function of Nod2 À / À DCs was normal. Investigation of colonic epithelial cell (CEC) innate responses revealed a significant reduction in epithelial production of the chemokines CCL2 and CCL5 but not CCL20 by Nod2-deficient CECs. Collectively, these data demonstrate the importance of Nod2 in CEC responses to infection and the requirement for functional Nod2 in initiating host epithelial chemokine-mediated responses and subsequent DC recruitment and T-cell responses following infection. INTRODUCTION characterized, how and why these immune responses are The gastrointestinal-dwelling parasite, Trichuris muris initiated is still unclear.
    [Show full text]
  • Involvement of Fas/Fasl Pathway in the Murine Model of Atopic Dermatitis
    Inflamm. Res. DOI 10.1007/s00011-017-1049-z Inflammation Research ORIGINAL RESEARCH PAPER Involvement of Fas/FasL pathway in the murine model of atopic dermatitis 1 1,2 1 1 Karolina Bien´ • Magdalena Zmigrodzka_ • Piotr Orłowski • Aleksandra Fruba • 1 1 3 4 Łukasz Szyman´ski • Wanda Stankiewicz • Zuzanna Nowak • Tadeusz Malewski • Małgorzata Krzyzowska_ 1 Received: 28 April 2016 / Revised: 8 February 2017 / Accepted: 14 March 2017 Ó The Author(s) 2017. This article is an open access publication Abstract levels in blood as well as increased expression of IL-1b, Objective and design The aim of this study was to eluci- IL-4, IL-5, IL-13 and TGF-1b mRNA in comparison to date the role of apoptosis mediated through Fas/FasL wild-type mice. On the other hand, expression of CXCL9 pathway using the mouse model of atopic dermatitis (AD). and CXCL10, IL-17 mRNAs in the skin samples in Fas- Materials and treatment AD was induced by epicutaneous and FasL-deficient mice was decreased. application of ovalbumin (OVA) in wild-type C57BL/6, Conclusions Our results show that lack of the Fas-induced B6. MRL-Faslpr/J (Fas-) and B6Smn.C3-Faslgld/J apoptosis leads to exacerbation of AD characteristics such (FasL-) mouse strains. as Th2 inflammation and dermal thickening. Therefore, Fas Methods Skin samples were subjected to staining for Fas/ receptor can play an important role in AD pathogenesis by FasL expression, M30 epitope and assessment of inflam- controlling development of the local inflammation. matory response via immunohistochemical staining. Cytokine and chemokine production was assessed by real- Keywords Apoptosis Á Fas/FasL Á Atopic dermatitis Á time PCR.
    [Show full text]
  • LTR Signaling Controls Lymphatic Migration of Immune Cells
    cells Review LTβR Signaling Controls Lymphatic Migration of Immune Cells Wenji Piao 1,2, Vivek Kasinath 3, Vikas Saxena 2, Ram Lakhan 1,2, Jegan Iyyathurai 2 and Jonathan S. Bromberg 1,2,4,* 1 Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [email protected] (W.P.); [email protected] (R.L.) 2 Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [email protected] (V.S.); [email protected] (J.I.) 3 Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA; [email protected] 4 Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA * Correspondence: [email protected]; Tel.: +410-328-6430 Abstract: The pleiotropic functions of lymphotoxin (LT)β receptor (LTβR) signaling are linked to the control of secondary lymphoid organ development and structural maintenance, inflammatory or autoimmune disorders, and carcinogenesis. Recently, LTβR signaling in endothelial cells has been revealed to regulate immune cell migration. Signaling through LTβR is comprised of both the canonical and non-canonical-nuclear factor κB (NF-κB) pathways, which induce chemokines, cytokines, and cell adhesion molecules. Here, we focus on the novel functions of LTβR signaling in lymphatic endothelial cells for migration of regulatory T cells (Tregs), and specific targeting of LTβR signaling for potential therapeutics in transplantation and cancer patient survival. Keywords: lymphotoxin; lymphotoxin β receptor signaling; Treg migration; non-canonical nuclear Citation: Piao, W.; Kasinath, V.; factor κB pathway; lymphatic endothelial cells Saxena, V.; Lakhan, R.; Iyyathurai, J.; Bromberg, J.S.
    [Show full text]